Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.59 | 14.38 |
| PEG Ratio (TTM) | -0.51 | -4.82 |
| P/S Ratio (TTM) | 0.21 | 2.15 |
| P/B Ratio (TTM) | 1.66 | 6.10 |
| P/FCF Ratio (TTM) | 7.38 | 20.71 |
| Price to 5YR AVG Earnings Ratio | -73.34 | 25.88 |
| Price to 5YR AVG FCF Ratio | -154.11 | 28.79 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.24% | 9.32% |
| ROE (TTM) | 34.98% | 40.46% |
| Net Profit Margin (TTM) | 3.68% | 13.49% |
| ROIC 5YR AVG | 3.21% | 14.96% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.42% | -195.86% | -50.64% |
| Revenue | 0.75% | -0.50% | 5.99% |
| Net Income | 6.21% | -195.67% | -50.05% |
| Cash Flow | 679.40% | -40.28% | 53.28% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.36 | 2.27 |
| Quick Ratio (TTM) | 0.61 | 1.79 |
| D/E Ratio (TTM) | 0.88 | 2.05 |
| Interest Coverage (TTM) | 6.36 | 14.73 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 3.18 | 3.45 |
| LTL to 5YR AVG FCF | -53.21 | 6.99 |
| Shares Outstanding Growth 5YR AVG | 0.71% | -2.07% |